CANVAS-COVID Study Results

Results as of: November 24, 2021

Total persons enrolled in study

1 357 365

Vaccination dose received and survey completed:

DOSE 1

survey  completed

722,868

DOSE 2

survey  completed

384,997

People experiencing local reaction:

53%

Injection site pain/swelling/redness

Other health events that occurred after dose 1:

0%

9%

of people developed a new health event within 7 days of receiving their first dose

62,378 out of 722,868 doses

0%

5%

of people developed a new health event within 7 days that prevented daily activities/
work/required a medical visit

37,634 out of 722,868 doses

Other health events that occurred after dose 2:

0%

9%

of people developed a new health event within 7 days of receiving their second dose

33,359 out of 384,997 doses

0%

5%

of people developed a new health event within 7 days of receiving their second dose that prevented daily activities/work/required a medical visit

19,592 out of 384,997 doses

Most frequent other health events reported:

4.5%

Systemic symptoms

(fever, fatigue, muscle ache, feeling unwell)

3.3%

Headache or migraine

2.0%

Nausea, vomiting, diarrhea

Other events of interest:

Shingles is not occurring more frequently after vaccination

VACCINATED GROUP

0.03%

UNVACCINATED GROUP

0.03%